US Representative

Ronny Jackson 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 8)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB355

Introduced
1/13/23  
Back the Blue Act of 2023 This bill establishes new criminal offenses for killing, assaulting, and fleeing to avoid prosecution for killing a judge, law enforcement officer, or public safety officer. Additionally, the bill expands the list of statutory aggravating factors in death penalty determinations to also include the killing or attempted killing of a law enforcement officer, judge, prosecutor, or firefighter or other first responder; broadens the authority of federal law enforcement officers to carry firearms; and limits federal court review of challenges to state court convictions for killing a public safety officer or judge. Finally, it directs the Department of Justice to make grants to law enforcement agencies and nongovernmental organizations to promote trust and improve relations between law enforcement agencies and the communities they serve.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB356

Introduced
1/13/23  
Refer
1/13/23  
Unleashing American Energy Act This bill requires a minimum amount of oil and gas lease sales a year on certain submerged lands of the Outer Continental Shelf (OCS) and limits delays on federal oil and gas leases on such lands. Specifically, this bill requires the Department of the Interior to annually conduct a minimum of two region-wide oil and gas lease sales in each of the following regions of the OCS: (1) the Gulf of Mexico region in the Central Gulf of Mexico Planning Area and the Western Gulf of Mexico Planning Area, and (2) the Alaska region. In addition, the bill requires the President to obtain congressional approval before delaying federal oil and gas leases on the OCS.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3561

Introduced
5/22/23  
Refer
5/22/23  
PATIENT Act of 2023 Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3666

Introduced
5/25/23  
Refer
5/25/23  
SOS Act of 2023 Stop Our Scourge Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB371

Introduced
1/17/23  
Refer
1/17/23  
Defund Planned Parenthood Act of 2023 This bill restricts federal funding for Planned Parenthood Federation of America Inc. or any of its affiliates or clinics for one year. Specifically, it prohibits funding those entities unless they certify that the affiliates and clinics will not perform, and will not provide funds to entities that perform, abortions during that year. If the certification requirement is not met, the Department of Health and Human Services and the Department of Agriculture must recoup any federal assistance received by those entities. However, the bill's funding restriction does not apply to abortions performed in cases of rape or incest or when necessary to resolve a physical condition that endangers a woman's life. The bill also provides additional funding for community health centers for the one-year period. These funds are subject to the same abortion-related restrictions and exceptions.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3712

Introduced
5/25/23  
Digital Dollar Pilot Prevention Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB372

Introduced
1/17/23  
Refer
1/17/23  
Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3740

Introduced
5/26/23  
Federal Employee Student Debt Transparency Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3741

Introduced
5/23/23  
Refer
5/26/23  
To amend title X of the Public Health Service Act to prohibit funds under such title from being used for any system through which counseling or referrals are provided to individuals regarding abortion services.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3748

Introduced
5/30/23  
SAFE Act of 2023 Safe American Food Exports Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3774

Introduced
5/31/23  
Refer
5/31/23  
Report Pass
10/19/23  
SHIP Act Stop Harboring Iranian Petroleum Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3792

Introduced
6/1/23  
U.S.-Israel Partnership and Abraham Accords Enhancement Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB38

Introduced
1/9/23  
Concealed Carry Reciprocity Act This bill establishes a federal statutory framework to regulate the carry or possession of concealed firearms across state lines. Specifically, an individual who is eligible to carry a concealed firearm in one state may carry or possess a concealed handgun (other than a machine gun or destructive device) in another state that allows its residents to carry concealed firearms. It sets forth requirements for the lawful concealed carry across state lines. The bill preempts most state and local laws related to concealed carry and establishes a private right of action for a person adversely affected by interference with a concealed-carry right established by this bill.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB383

Introduced
1/17/23  
Refer
1/17/23  
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3641

Introduced
5/24/23  
Refer
5/24/23  
To direct the Secretary of Veterans Affairs to rescind guidelines and ensure the removal of signs and guidance relating to the COVID-19 pandemic.